Tuesday , December 12 2017
Home / KEEP BUT DO NOT DISPLAY / Alerts / January 19, 2013

January 19, 2013

 
FDA Advisory Committee Recommends Approval of First in Class SGLT-2(Canagliflozin).

Next Once Weekly GLP-1 (albiglutide) Submitted to FDA for Approval.

Looking for 10,000 seniors to participate in a free program to prevent diabetes (See Item #2).